This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/12/2397    most recent 01.ATV.0000146267.71816.30v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Annuzzi, G. Articles by Rivellese, A. A. Search for Related Content PubMed PubMed Citation Articles by Annuzzi, G. Articles by Rivellese, A. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Hazardous Substances DB GLUCOSE

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2397.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Insulin Resistance Is Independently Associated With Postprandial Alterations of Triglyceride-Rich Lipoproteins in Type 2 Diabetes Mellitus

Giovanni Annuzzi; Claudia De Natale; Ciro Iovine; Lidia Patti; Lucrezia Di Marino; Silvana Coppola; Stefano Del Prato; Gabriele Riccardi; Angela A. Rivellese

From the Department of Clinical and Experimental Medicine (G.A., C.D.N., C.I., L.P., L.D.M., S.C., G.R., A.A.R.), Federico II University, Naples, and the Department of Endocrinology and Metabolism (S.D.P.), University of Pisa, Italy.

Correspondence to Giovanni Annuzzi, MD, Department of Clinical and Experimental Medicine, Federico II University, Via Pansini 5, 80131 Napoli, Italy. E-mail annuzzi{at}unina.it

Objective— To evaluate the role of insulin resistance in development of postprandial dyslipidemia in type 2 diabetic patients in an experimental setting in which these patients were compared with nondiabetic subjects at similar glucose and insulin blood levels.

Methods and Results— Eight type 2 diabetic patients in optimal blood glucose control and 7 control subjects (aged 50.0±2.6 and 48.1±1.3 years; body mass index 28.3±1.2 and 25.6±1.1 kg/m²; fasting plasma triglycerides 1.12±0.13 and 0.87±0.08 mmol/L, respectively; mean±SEM; NS) consumed a mixed meal during an 8-hour hyperinsulinemic glycemic clamp. Mean blood glucose during clamp was 7.8 mmol/L, and plasma insulin during the preprandial steady state was 480 pmol/L in both groups, that differed for insulin sensitivity (M/I value lower in diabetic subjects [1.65±0.30 and 3.42±0.60; P<0.05]). Subjects with diabetes had higher postprandial levels of lipids and apolipoprotein B (apoB) in large very low-density lipoprotein (incremental area for triglycerides 1814±421 versus 549±153 µmol/Lx6 hours; P<0.05; cholesterol 694±167 versus 226±41 µmol/Lx6 hours; P<0.05; apoB-48 6.3±1.0 versus 2.6±0.7 mg/Lx6 hours; P<0.05; apoB-100 56.5±14.9 versus 26.2±11.0 mg/Lx6 hours; NS). Basal lipoprotein lipase (LPL) activity before and after meal was higher in diabetic subjects, whereas postheparin LPL activity 6 hours after the meal was similar.

Conclusions— Insulin resistance is also associated with postprandial lipoprotein abnormalities in type 2 diabetes after acute correction for hyperglycemia and hyperinsulinemia.

In an experimental setting, taking care of the effects of hyperglycemia and hyperinsulinemia (hyperinsulinemic glycemic clamp,) insulin-resistant type 2 diabetic patients showed higher postprandial levels of lipids and apoB in large VLDL compared with controls, indicating that insulin resistance is a proper target to correct postprandial dyslipidemia in type 2 diabetes.

Key Words: postprandial lipemia • large VLDL • insulin resistance • type 2 diabetes • lipoprotein lipase

This article has been cited by other articles:

				B. Fagerberg, H. Schuster, G. S. Birketvedt, S. Tonstad, K. P. Ohman, and I. Gause-Nilsson Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPAR{alpha}/{gamma} agonist, tesaglitazar Diabetes and Vascular Disease Research, September 1, 2007; 4(3): 174 - 180. [Abstract] [PDF]

				K. F Hilpert, S. G West, P. M Kris-Etherton, K. D Hecker, N. M Simpson, and P. Alaupovic Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes Am. J. Clinical Nutrition, February 1, 2007; 85(2): 369 - 376. [Abstract] [Full Text] [PDF]

				T. Tzotzas, M. Samara, T. Constantinidis, K. Tziomalos, and G. Krassas Short-term Administration of Orlistat Reduced Daytime Triglyceridemia in Obese Women With the Metabolic Syndrome Angiology, February 1, 2007; 58(1): 26 - 33. [Abstract] [PDF]

				H. Koga, S. Sugiyama, K. Kugiyama, H. Fukushima, K. Watanabe, T. Sakamoto, M. Yoshimura, H. Jinnouchi, and H. Ogawa Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease Eur. Heart J., April 1, 2006; 27(7): 817 - 823. [Abstract] [Full Text] [PDF]